Skip to main content
SpringerPlus

Table 3 The main differences in the defined assessment measures with TNF-I at 6 months

From: Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease

Measures

Responders

Non responders

Significance

P-value

ESR

23.56 ± 13.58

28 ± 16.87

<0.05*

CRP

6.66 ± 4.81

14.82 ± 17.90

<0.05*

Hb%

12.61 ± 1.09

12.01 ± 0.87

>0.05

DAS-28

2.80 ± 1.15

4.35 ± 1.24

<0.05*

RF at 6 months

118.84 ± 127.55

66.60 ± 74.16

<0.05*

  1. *P value< 0.05 is considered statistically significant.
Back to article page